<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04887922</url>
  </required_header>
  <id_info>
    <org_study_id>202105028</org_study_id>
    <nct_id>NCT04887922</nct_id>
  </id_info>
  <brief_title>Preoperative and Postoperative Incentive Spirometry in Patients Undergoing Major Abdominal Surgery</brief_title>
  <official_title>The Effect of Preoperative and Postoperative Incentive Spirometry in Patients Undergoing Major Abdominal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to determine the efficacy of incentive spirometry (IS) to improve&#xD;
      pulmonary function in the preoperative and postoperative surgical setting. The investigators&#xD;
      hypothesize that IS will improve pulmonary function for patients undergoing major abdominal&#xD;
      surgery when controlling for protocol compliance. Additionally, the investigators hypothesize&#xD;
      that a digital IS device enabled with a text message-based mobile health intervention will&#xD;
      improve pulmonary pre-habilitation and rehabilitation, as well as postoperative compliance&#xD;
      with the IS device.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 31, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Prior to surgery, participants will be randomized into three groups: (1) control group with no IS, (2) standard IS, and (3) digital IS + text message.&#xD;
Following surgery, patients will be re-randomized into two groups: (1) standard IS, and (2) digital IS + text message.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in FEV1</measure>
    <time_frame>From baseline to day-of-surgery preoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in FVC</measure>
    <time_frame>From baseline to day-of-surgery preoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pulse oximetry</measure>
    <time_frame>From baseline to day-of-surgery preoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in FEV1</measure>
    <time_frame>From day 1 to postoperative day 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in FVC</measure>
    <time_frame>From day 1 to postoperative day 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pulse oximetry</measure>
    <time_frame>From day 1 to postoperative day 3</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">156</enrollment>
  <condition>Abdominal Surgery</condition>
  <arm_group>
    <arm_group_label>Pre-Surgery: No Incentive Spirometry (IS)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>-Will not receive a incentive spirometer prior to surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pre-Surgery: Standard Incentive Spirometry (IS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Will receive a conventional spirometer prior to surgery&#xD;
Will be asked to perform spirometry 10 times per hour, every hour while awake, every day for at least 7 days prior to surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pre-Surgery: Digital Incentive Spirometry (IS) + Text Message</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Will receive the digital incentive spirometer (Spirobank G) that is compatible with health monitoring software developed by ZEPHYRx速. The digital spirometer couples with a HIPAA-compliant mobile application that calculates and stores pulmonary function test (PFT) results.&#xD;
Will be asked to perform spirometry 10 times per hour, every hour while awake, every day for at least 7 days prior to surgery. Absence of spirometry for 24 hours will trigger a text message reminder to encourage compliance with IS.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-Surgery: Standard Incentive Spirometry (IS)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After surgery, the participants will receive a conventional spirometer.&#xD;
Will be instructed to perform spirometry 10 times per hour, every hour while awake through postoperative Day 3&#xD;
The conventional spirometer will be equipped with an accelerometer that will allow the research team to determine whether the spirometer moves throughout the patients' postoperative stay (as a proxy for IS use)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-Surgery: Digital Incentive Spirometry (IS) + Text Message</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After surgery, the participants will receive the digital incentive spirometer (Spirobank G) that is compatible with health monitoring software developed by ZEPHYRx速. The digital spirometer couples with a HIPAA-compliant mobile application that calculates and stores pulmonary function test (PFT) results.&#xD;
Will be instructed to perform spirometry 10 times per hour, every hour while awake through postoperative Day 3&#xD;
Will receive text reminders to perform spirometry if they do not perform spirometry in a 24-hour period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MIR Spirobank G</intervention_name>
    <description>FDA-approved, Bluetooth digital spirometer</description>
    <arm_group_label>Post-Surgery: Digital Incentive Spirometry (IS) + Text Message</arm_group_label>
    <arm_group_label>Pre-Surgery: Digital Incentive Spirometry (IS) + Text Message</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ZEPHYRx速</intervention_name>
    <description>ZEPHYRx速 has developed a 1) digital Bluetooth-enabled IS that allows for the continuous and objective remote monitoring of patient compliance with pre- and postoperative IS via a smartphone app and online provider dashboard.</description>
    <arm_group_label>Post-Surgery: Digital Incentive Spirometry (IS) + Text Message</arm_group_label>
    <arm_group_label>Pre-Surgery: Digital Incentive Spirometry (IS) + Text Message</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional spirometer</intervention_name>
    <description>Will be provided to participants</description>
    <arm_group_label>Post-Surgery: Standard Incentive Spirometry (IS)</arm_group_label>
    <arm_group_label>Pre-Surgery: Standard Incentive Spirometry (IS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients scheduled to undergo major abdominal surgery with expected postoperative&#xD;
             length of stay of 48 hours or more.&#xD;
&#xD;
          -  Access to a smartphone.&#xD;
&#xD;
          -  At least 18 years of age.&#xD;
&#xD;
          -  Ability to understand and willingness to sign an IRB approved written informed consent&#xD;
             document.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Younger than 18 years of age&#xD;
&#xD;
          -  No access to a smartphone&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chet Hammill, M.D., MCR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chet Hammill, M.D., MCR</last_name>
    <phone>314-273-1809</phone>
    <email>hammillc@wustl.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Chet Hammill, M.D., MCR</last_name>
      <phone>314-273-1809</phone>
      <email>hammillc@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Chet Hammill, M.D., MCR</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dominic Sanford, M.D., MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>William Hawkins, M.D., FACS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven Strasberg, M.D., FACS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ryan Fields, M.D., FACS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jorge Zarate Rodriguez, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Esther Lu, M.S., Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gregory Williams, M.A.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.siteman.wustl.edu</url>
    <description>Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 10, 2021</study_first_submitted>
  <study_first_submitted_qc>May 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2021</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

